Companies
Siemens Healthineers
Siemens Healthineers reported €23.4 billion in FY25 revenue (+5% year on year), led by €12.1 billion in imaging, anchoring a German medtech belt alongside B. Braun and Fresenius.
- Country
- Germany
- Ticker
- ETR:SHL
Medical imaging
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Headcount | approximately 74,000 employees worldwide as of September 30, 2025 | eqs-news.com · siemens-healthineers.com |
| Revenue | €23.4 billion for fiscal year 2025 | eqs-news.com · medicalbuyer.co.in · siemens-healthineers.com |
| Production site | Germany, United States, India, China, Great Britain, Republic of Korea, and Slovakia | vimda.moh.gov.vn · eqs-news.com · siemens-healthineers.com |
| Certification | EN ISO 13485:2016 for medical device quality management systems | vimda.moh.gov.vn · scribd.com · siemens-healthineers.com |
| Certification | ISO 9001 for quality management systems | siemens-healthineers.com |
| Certification | ISO 14001 for environmental management systems | siemens-healthineers.com |
| Certification | ISO 45001 for health and safety management systems | siemens-healthineers.com |
| Regulatory approval | Compliance with EU Data Act requirements for connected products effective September 2025 medium confidence | eqs-news.com |
| Capacity | Facility in Sudbury, UK, manufactures and ships instruments and consumables globally for urinalysis, diabetes, and blood gas analytics medium confidence | siemens-healthineers.com |
Independent sources: eqs-news.com · medicalbuyer.co.in · scribd.com · vimda.moh.gov.vn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biomedical engineering & implants | regenerative-personalized | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.